Cargando…
Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art
Disease prognosis is very poor in patients with brain tumors. Cognitive deficits due to disease or due to its treatment have an important weight on the quality of life of patients and caregivers. Studies often take into account quality of life as a fundamental element in the management of disease an...
Autores principales: | Bergo, E., Lombardi, G., Pambuku, A., Della Puppa, A., Bellu, L., D'Avella, D., Zagonel, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963561/ https://www.ncbi.nlm.nih.gov/pubmed/27493954 http://dx.doi.org/10.1155/2016/3041824 |
Ejemplares similares
-
An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016) -
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
por: Del Bianco, Paola, et al.
Publicado: (2022) -
Presurgical predictors of early cognitive outcome after brain tumor resection in glioma patients
por: Zangrossi, Andrea, et al.
Publicado: (2022) -
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)